Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 10/20 | 0.62 |
| ▸ | BCHE | P06276 | 6/20 | 0.58 |
| ▸ | ACHE | P22303 | 5/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.51 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4848357 | 0.93 | MAOB (0.60) | MAOBBCHEACHEMAOAAPP | |
| SCHEMBL25202533 | 0.88 | BCHE (0.65) | MAOBBCHEACHEMAOAKDM4E | |
| SCHEMBL4846713 | 0.88 | MAOB (0.58) | MAOBBCHEACHEMAOAAPP | |
| SCHEMBL4852919 | 0.87 | BCHE (0.56) | MAOBBCHEACHEMAOACYSLTR2 | |
| SCHEMBL4847371 | 0.87 | MAOB (0.52) | MAOBBCHEACHEMAOA | |
| SCHEMBL4854115 | 0.85 | MAPT (0.63) | BCHEACHEAPP | |
| SCHEMBL4851228 | 0.83 | ABCG2 (0.60) | MAOBBCHEACHEMAOAAPP | |
| SCHEMBL4845309 | 0.83 | ABCG2 (0.60) | MAOBBCHEACHEMAOAAPP | |
| SCHEMBL4846963 | 0.82 | TUBB1 (0.56) | BCHEACHEAPPALDH1A1 | |
| SCHEMBL4849629 | 0.81 | KDM4E (0.56) | MAOBBCHEACHEAPPKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050227990-A1 | Aminoalkoxy-functional chalcones | LICA PHARMACEUTICALS A/S (DK) | 2005-10-13 | — | — | US | claimed |
| US-7423181-B2 | in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone | LICA PHARMACEUTICALS A/S (DK) | 2008-09-09 | — | — | US | disclosed |
| US-20050227990-A1 | Aminoalkoxy-functional chalcones | LICA PHARMACEUTICALS A/S (DK) | 2005-10-13 | — | — | US | disclosed |